The talks on drugs including Novo Nordisk's Wegovy, GSK's Trelegy Ellipta, and Pfizer's Xtandi will set Medicare prices that ...

U.S. Health and Human Services Secretary Xavier Becerra says “this is a big deal.” Drug companies oppose the program.

Click in for more news from The Hill{beacon} Health Care Health Care   The Big Story Biden adds Ozempic to list for Medicare price negotiationIn one of its last actions, the Biden ...

Federal officials are targeting the blockbuster drugs as part of their ongoing initiative to lower drug costs.

TD Cowen analysts estimate that about 45% of U.S. sales for Ozempic and Rybelsus each goes through Medicare Part D.

The Centers for Medicare & Medicaid Services announced 15 new drugs it wants to lower the cost for, including popular, but ...

Health insurers are limiting coverage of prosthetic limbs, questioning their medical necessity. Advocates say it is ...

He added that the additional assistance “will provide Ukraine with both an immediate influx of capabilities that it continues to use to great effect on the battlefield and longer-term supplies ...

This latest congressional failure comes despite AMA’s leading the charge to reform the Medicare payment system to avoid what Dr. Scott has called an “oncoming crisis” in medical care. That advocacy ...

In March, the U.S.Centers for Medicare ... the approved use of Wegovy to include reducing heart risks for adults who are obese or overweight. "Ignoring This Can Be Life Or Death": Medical Pros ...

(Reuters) -The U.S. Food and Drug Administration on Friday approved Eli Lilly's weight ... Government-backed Medicare plans for adults aged 65 and older and those with disabilities are barred ...